Protective Effects of -Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury.

TitleProtective Effects of -Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury.
Publication TypeJournal Article
Year of Publication2020
AuthorsPiscitelli, F, Guida, F, Luongo, L, Iannotti, FArturo, Boccella, S, Verde, R, Lauritano, A, Imperatore, R, Smoum, R, Cristino, L, Lichtman, AH, Parker, LA, Mechoulam, R, Maione, S, Di Marzo, V
JournalACS Chem Neurosci
Date Published2020 Apr 02
ISSN1948-7193
Abstract

Traumatic brain injury (TBI) is one of the main causes of death in young people for which currently no efficacious treatment exists. Recently, we have reported that mice with mild-TBI with a specific injury in the insula showed elevated levels of a little investigated -acyl amino acid, -oleoylglycine (OlGly). -acyl amino acids have recently experienced an increased interest because of their important biological activities. They belong to the endocannabinoidome family of lipids with structural similarities with the endocannabinoids (eCBs). The aim of this study was to test the neuroprotective and antihyperalgesic actions of OlGly in a model of mouse mild-TBI (mTBI) and its effect on levels of eCBs and -acylethanolamines at the end of treatment. Following mTBI, mice were administered a daily injection of OlGly (10-50-100 mg/kg i.p.) for 14 days. Treatment with OlGly normalized motor impairment and behavior in the light/dark box test, ameliorated TBI-induced thermal hyperalgesia and mechanical allodynia, and normalized aggressiveness and depression. Moreover, levels of eCBs and some -acylethanolamines underwent significant changes 60 days after TBI, especially in the prefrontal cortex and hypothalamus, and OlGly reversed some of these changes. In conclusion, our findings reveal that OlGly ameliorates the behavioral alterations associated with mTBI in mice, while concomitantly modulating eCB and eCB-like mediator tone.

DOI10.1021/acschemneuro.9b00633
Alternate JournalACS Chem Neurosci
PubMed ID32017529